Divisas / CORT
CORT: Corcept Therapeutics Incorporated
68.39
USD
0.95
(1.37%)
El tipo de cambio de CORT de hoy ha cambiado un -1.37%. En este caso, el precio mínimo en el mercado ha alcanzado 67.61, mientras que el máximo ha alcanzado 70.10.
Siga la dinámica de la pareja de divisas Corcept Therapeutics Incorporated. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CORT News
- Seeking Alpha ClearBridge Small Cap Strategy Q2 2025 Commentary
- Zacks Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last?
- Seeking Alpha XPH: Healthcare Dashboard For July (NYSEARCA:XPH)
- Zacks Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
- Investing Corcept submits new drug application for ovarian cancer treatment
- Investing Piper Sandler reiterates Overweight rating on Corcept Therapeutics stock
- Seeking Alpha ClearBridge Global Value Improvers Strategy Q2 2025 Commentary
- Investing Corcept therapeutics officer Guyer sells $7350 in shares
- Seeking Alpha Beyond Cushing’s: The Undervalued Potential Of Corcept's Cortisol Modulators
- Investing Truist reiterates buy rating on Corcept stock, citing diabetes opportunity
- Seeking Alpha Calamos Timpani Small Cap Growth Fund Q1 2025 Commentary
- Investing Cortisol modulator improves glucose control in diabetes patients
- Seeking Alpha IHE: Healthcare Dashboard For June (NYSEARCA:IHE)
- Investing Corcept reports annual meeting outcomes
- Investing Corcept May 2025 slides: Revenue target of $900-950M amid pipeline advances
- Seeking Alpha Corcept: Remains A Strong Buy On Recent Weakness And Aggressive Sales Force Hiring
- Investing Corcept Therapeutics director Daniel Swisher sells $155k in stock
- Seeking Alpha American Century Small Cap Growth Fund Q1 2025 Commentary
- Seeking Alpha Tracking RenTech’s 13F Portfolio – Q1 2025 Update
- Seeking Alpha Harbor AlphaEdge Small Cap Earners ETF Q1 2025 Commentary (EBIT)
- Benzinga Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study - Corcept Therapeutics (NASDAQ:CORT)
- Investing Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting
- Investing Corcept therapeutics officer Joseph Lyon sells shares worth $390,218
- Seeking Alpha abrdn U.S. Small Cap Equity Fund Q1 2025 Commentary
Rango diario
67.61
70.10
Rango anual
32.39
117.34
- Cierres anteriores
- 69.08
- Open
- 69.34
- Bid
- 68.39
- Ask
- 68.69
- Low
- 67.61
- High
- 70.10
- Volumen
- 1.832 K
- Cambio diario
- -1.37%
- Cambio mensual
- -6.70%
- Cambio a 6 meses
- 4.67%
- Cambio anual
- 76.86%
24 julio, jueves
12:30
USD
- Act.
- Pronós.
- -0.12
- Prev.
- -0.28
12:30
USD
- Act.
- Pronós.
- 215 K
- Prev.
- 221 K
12:30
USD
- Act.
- Pronós.
- 1.972 M
- Prev.
- 1.956 M
12:30
USD
- Act.
- Pronós.
- 225.813 K
- Prev.
- 229.500 K
14:00
USD
- Act.
- Pronós.
- 0.684 M
- Prev.
- 0.623 M
14:00
USD
- Act.
- Pronós.
- -3.2%
- Prev.
- -13.7%
14:30
USD
- Act.
- Pronós.
- 20 B
- Prev.
- 46 B
15:00
USD
- Act.
- Pronós.
- -2
- Prev.
- -2
15:00
USD
- Act.
- Pronós.
- -5
- Prev.
- 5
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.230%
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.270%
17:00
USD
- Act.
- Pronós.
- Prev.
- 2.220%